MedTrace Logo

The Effect of Probiotics on Asthma Risk in Animal Laboratory Workers

NCT03021161 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-01-13

No results posted yet for this study

Summary

This project will be test the effect of probiotics on occupational allergic sensitization, respiratory symptoms and bronchial hyperresponsiveness in workers or students that develop respiratory symptoms exposed to laboratory animals, i.e., small rodents.

Conditions

  • Asthma Occupational

Interventions

DRUG

Probiotic Formula

The intervention group will receive once daily capsules containing 109 CFU of Lactobacillus rhamnosus HN001, Lactobacillus paracasei Lpc-37 and Bifidobacterium animalis ssp. Lactis HN019

OTHER

Placebo Oral Capsule

Capsule containing no probiotic

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    collaborator OTHER

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Elcio O Vianna, MD, PHD · University of S. Paulo Medical School of Rib. Preto

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-12-31
Completion
2020-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03021161 on ClinicalTrials.gov